Xeomin is a botulinum toxin type A injectable treatment used to temporarily improve the appearance of moderate to severe frown lines between the eyebrows (glabellar lines) in adults. The time it takes to observe the effects of this treatment is a common point of interest for individuals considering or receiving the injections.
Understanding the expected timeline is important for managing expectations and planning future treatments. While individual experiences can vary, a general understanding of the onset and duration of effects allows for informed decisions regarding cosmetic procedures and aesthetic goals. The longevity of the effects also factors into the overall value and convenience of this type of cosmetic intervention.